Physician

Amber Nardandrea Pepper, MD

According to 2025 Medicare claims, Amber Pepper, MD (NPI: 1013259407) practices allergy/immunology in the Tampa, FL market, with the plurality of this provider's patient population coming from Hillsborough, FL. This provider's primary affiliated billing organization is GLAUM & CHO M.D.S, P.A. (NPI: 1588649263; TIN: 592612475) and primary practice location at 33613-3946. Pepper is affiliated with the Caravan Collaborative Pathways (ACO ID: A4604), participating under the MSSP model.

Pepper's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 134 traditional Medicare patients, billed 4,217 HCPCS/CPT codes, and received $109,798 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 518 prescription claims across 109 beneficiaries totaling $219,766 in drug costs, led by Hizentra (Immun Glob G(Igg)/Pro/Iga 0-50). DME data shows 353 claims. Open Payments data shows 105 records totaling $103,204. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $3,023 to $109,798. Similarly, Part D prescription costs have moved sharply higher in recent years, from $417 to $219,766. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $545 to $7,342.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$55K$110K2018 Medicare payment: $3,023 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $5,963 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $41,412 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $68,280 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $45,790 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $69,167 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $109,798 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
201817108$3,023
201937413$5,963
20201031,937$41,412
20211462,951$68,280
20221272,189$45,790
20231112,241$69,167
20241344,217$109,798

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$140K$281K2015 Drug cost: $417 (USD; Tot_Drug_Cst)2016 Drug cost: $317 (USD; Tot_Drug_Cst)2018 Drug cost: $2,979 (USD; Tot_Drug_Cst)2019 Drug cost: $14,810 (USD; Tot_Drug_Cst)2020 Drug cost: $37,374 (USD; Tot_Drug_Cst)2021 Drug cost: $120,778 (USD; Tot_Drug_Cst)2022 Drug cost: $234,299 (USD; Tot_Drug_Cst)2023 Drug cost: $280,883 (USD; Tot_Drug_Cst)2024 Drug cost: $219,766 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/R16$417
2016N/R23$317
2017N/RN/RN/R
20181535$2,979
20193788$14,810
202087262$37,374
202196400$120,778
2022105460$234,299
2023102508$280,883
2024109518$219,766

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$243K$486K2020 Medicare payment: $36,019 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $139,212 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $415,055 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $485,501 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $448,829 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/R45$36,019
2021N/R116$139,212
2022N/R297$415,055
202311405$485,501
2024N/R353$448,829

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more4141$119
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more4168$86
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more6895$65
94060Test to measure expiratory airflow and volume changes before and after medication administration1821$24
96160Administration and interpretation of patient-focused health risk assessment2945$2

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
HizentraImmun Glob G(Igg)/Pro/Iga 0-5016448$119,135
Trelegy ElliptaFluticasone/Umeclidin/Vilanter451,470$30,980
Breo ElliptaFluticasone/Vilanterol20600$7,438
SymbicortBudesonide/Formoterol Fumarate24840$6,509
EpinephrineEpinephrine20528$3,467

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
J1555Injection, immune globulin (cuvitru), 100 mgNN/R37$168,493
J1559Injection, immune globulin (hizentra), 100 mgNN/R48$148,822
J1561Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mgNN/R19$43,952
J1575Injection, immune globulin/hyaluronidase, (hyqvia), 100 mg immuneglobulinNN/R14$37,772
J1558Injection, immune globulin (xembify), 100 mgNN/R12$36,210

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.68$3,083Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.37$100,121Novartis Pharmaceuticals Corporation
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Amber Nardandrea Pepper, MD?

Tedicare shows public-source Medicare data for Amber Nardandrea Pepper, MD (NPI 1013259407), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amber Nardandrea Pepper, MD have ACO affiliation data?

Amber Nardandrea Pepper, MD is shown with ACO affiliation data for Caravan Collaborative Pathways (MSSP, ACO ID A4604).

What billing organization is linked to Amber Nardandrea Pepper, MD?

Amber Nardandrea Pepper, MD is linked to GLAUM & CHO M.D.S, P.A. (billing NPI 1588649263) in the available physician profile data.

Does Amber Nardandrea Pepper, MD have Open Payments data?

Amber Nardandrea Pepper, MD has 105 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.